Stockchase Index

STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 0 registered members and 32 guests viewing the site.Rss Top Picks FeedRss Daily Feed

Get more information on this Stock Research and Market Analysis Tool

Systems Xcellence
Symbol: SXC-T
Active: Y
Sector: computer software/processing
Notes:Do back office transaction between pharmacies, payer, insurance company, etc. Good product.
Last Price: 15.850
Last Price Date: 2008-08-21 18:09:09
Globe 200 day average

Experts that have talked about Systems Xcellence

TOP PICK15.280Robert FloydProvides a backend solution for healthcare services companies. Large acquisition had some dilutive effects on earnings but will be back on track next year.2008-06-24
TOP PICK16.170Robert FloydBack office solutions for Pharmacy/health benefit providers. Health card systems will change the shape of the company.2008-05-30
TOP PICK14.670Robert FloydProvide the back-office systems for pharmacies. Made an interesting acquisition, which will add substantially to their overall business. Also announced a contract with Tennessee.2008-04-29
TOP PICK10.480Robert FloydProvide the back end solution for a lot of pharmacies, and companies of that type. Are making acquisition of National Health in the states for $143 million, who is one of their major customers. Will add substantially to the size of the company. Last quarter was back on track, compared to the past.2008-03-20
PAST TOP PICK16.170Robert Floyd(A Top Pick Feb 1`3/07. Down 32%.) Provide back-office solutions for lot of healthcare providers. Really likes this one now. Has gone through some of the tough times. Still a Buy.2008-01-15
PAST TOP PICK14.510Hugh Cleland, CFA(A Top Past Pick Dec14/06. Down 35.1%.) Still likes and is still buying.2007-12-27
BUY13.750Alex RuusPharmacy benefit management. Their solution is undercutting the big incumbents in the US. Really likes this story going forward. Likely bottoming and there should be good performance in 08.2007-12-13
Comment12.160Hugh Cleland, CFAFundamental problems drove the stock down. Has a good business model in pharmacy benefit management, which they can do for $2 per prescription that others need $5 for. Should give them a lot of traction. Missed Q2 earnings estimates and guided down for the year. Also made a mistake causing the state of Georgia to disallow them. They hope to get this back on track.2007-11-23
PAST TOP PICK12.200Lesley Marks(A Top Pick June 26/07. Down 60%.) Had just announced a possible $27 million contract at that time. They also missed on their quarter. Sold her holdings when they didn't get the contract.2007-11-15
BUY12.170Robert FloydProvides back-office systems to pharmacies. Have sustainable revenues. A few issues this year in terms of earnings expectations. Built a staff a little bit beyond where they should have been. Had to pare back operations modestly. Trying to refocus into the higher growth area. Good price.2007-11-14
BUY15.820Hugh Cleland, CFAVery visible cash flow and high margins. Gaining increased market share in the pharmacy management industry. Missed their numbers for the June quarter and lowered their guidance. Value managers are now buying. Revenues and expenses are in the US so a stronger Cdn$ does not affect them.2007-09-28
PAST TOP PICK18.590Hugh Cleland, CFA(A Top Pick Sept 7/06. Up 14%.) Prescription processing between pharmacies, patients and insurance in the US. Still buying below $20US.2007-09-07
BUY30.850Robert FloydProvides back-office for pharmacies. Located in Canada and US. Have been winning quite a few extensive contracts.2007-07-12
TOP PICK29.490Lesley MarksHealthcare information technology. Not a cyclical business. Good underlying growth. They can sell into their customer base to offer value added to decrease costs.2007-06-26
TOP PICK27.490Robert FloydBack-office solution for pharmacies, both in the US and Canada. Doing a very good job of building out their product base. Extremely strong earnings/revenue growth.2007-05-30
TOP PICK26.480Hugh Cleland, CFA(A Top Pick Sept 7/06. Up 60%.) Has had this in his portfolio for 5 years and expects it to be there another 5 years. A fantastic entry point on a 6 to 12 month basis.2007-05-24
PAST TOP PICK26.120Robert Floyd(A Top Pick May 16/06. Up 50.1%.) Back-office solution for pharmacies. Revenues are ticking along quite nicely. Still a Buy.2007-05-11
TOP PICK24.830Robert FloydProvides back end solutions to pharmacies. Does a very good job of providing very efficient solutions. Revenues have been growing dramatically. Good margins and good growth.2007-04-19
PAST TOP PICK21.400Hugh Cleland, CFA(A Top Pick Sept 7/06. Up 29.8%.) Has gone a little quiet. Had great 2007 guidance.2007-03-26
DON'T BUY22.880Robert McWhirterJust announced a new $5 million contract. Ranks neutral in his model. Earnings were down 12%. High P/E of 29. Recently sold his holdings.2007-02-28
TOP PICK23.460Robert FloydProvides software for the pharmacy business. Very strong balance sheet.2007-02-13
HOLD24.370Robert McWhirter87 ranking in the model, which is quite high. Likes their recurring revenue. Bidding on a large number of medical contracts. Strong Hold.2007-01-25
PAST TOP PICK23.900Hugh Cleland, CFA(A Top Pick Sept 7/06. Up 38.4%.) Still likes. Traction they are getting with their disruptive business model is changing the face of the pharmacy benefit industry in the US.2007-01-24
TOP PICK22.230Robert FloydProvides software for the pharmacy sector. North American wide now. A lot of operations in the US as well as Canada. Very strong growth rate. Guidance is for $.72. Strong balance sheet and could make an acquisition which would add to earnings.2007-01-19
TOP PICK23.650Robert FloydProvide pharmaceutical software for a growing need of companies that need these services. Has been growing quite dramatically.2007-01-03
BUY23.450Robert FloydProvide software services for the payer market on the pharmaceutical side.. Has had a terrific move this year. Their growth is phenomenal. Looking for it to move higher.2006-12-19
TOP PICK22.470Hugh Cleland, CFA(A Top Pick Sept 7/06. Up 32.9%.) Successfully introduced a business model into the pharmacy benefit management industry. Last 3 contracts have been real company transforming events. Cheap. A 3 to 5 year hold.2006-12-14
DON'T BUY21.220Robert McWhirterIn the top 25% of the database. Sold his holdings when he thought the stock was running out of gas. Bidding on some very substantial contracts, which is why the stock spiked up. Expensive.2006-11-28
SELL17.300Robert McWhirterThings are slowing down with the company. Made a ton of sales and money on the conversion to Medicare part D. 70% of their income is from recurring revenue. Feels they will have a 30% tax increase. Sold his holdings.2006-10-25
PAST TOP PICK18.450Robert Floyd(A Top Pick Sept 29/05. Up 100.2%.) Sells software to pharmacies, etc. US legislation allowed additional Americans to get coverage under Medicaid. Growth rate is very strong.2006-10-13
PAST TOP PICK18.810Robert Floyd(A Top Pick Sept 29/05. Up 708.3%.) Still sees some pretty good earnings expectations.2006-09-20
TOP PICK16.690Hugh Cleland, CFADevelopments over the next year in a number of different areas in their business could be a potential double from here. Risk/reward is very good.2006-09-07
PAST TOP PICK15.680Robert Floyd(A Top Pick May 16/06. Down 10.2%.) Consolidated the stock and also did an issue and are looking to an acquisition in the US. Earnings outlook is still extremely strong.2006-08-18
TOP PICK14.800Robert FloydIn a very interesting position. Involved in the pharmacy business, streamlining operations with their software. Have announced a number of contracts over the last little while. Earnings will be quite strong.2006-08-02
BUY13.160Robert McWhirterRanks 51 in his model, which is in the top 10%. Earnings expected to go from $.50 to $.75. Have a huge amount of recurring revenue. A non-cyclical company.2006-07-25
TOP PICK12.990Robert FloydBasically supplies software solutions for pharmacies. Growth rate has been very strong and is still in place. Looking for provincial contracts in Newfoundland and Quebec.2006-07-14
BUY14.360Robert McWhirterHad a consolidation of 4 to 1. In the top 5% of his database. Expecting a 55% earnings growth. Some big opportunities coming over the next several months. Likes their recurring revenue.2006-06-21
HOLD4.060Peter HodsonLikes what they are doing from an execution point of view. Will be listed on NASDAQ and thinks the US investors will like the story.2006-06-06
TOP PICK4.350Robert FloydProvide software services to pharmacies. Have been providing a nice return of late. Numbers are very strong and continue to look strong going forward. Very popular product, both in Canada and the US.2006-05-16
BUY4.030Robert McWhirterSystems Excellence has good earnings. It has done well over the last year. It is a good opportunity. One of his top ten holdings. Ranks 16 in the database. It should survive even if we have a market pull back.2006-03-13
TOP PICK2.590Howard SuttonA defensive play in that 90% of their backlogs is recurring. They are in the software and service business, managing prescription benefit programs. Got into a new business about a year ago giving more into the pharmaceutical system. There is a US law on January 1 that will be a boon to this company.2005-12-22
TOP PICK2.290Robert FloydThe company is interesting. They provide software to pharmacies to streamline their operations. The company has jusy got a big contract. Earnings will be $0.09 this year and $0.13 next year.2005-09-29
BUY on WEAKNESS2.200Robert McWhirterRanks highly his database. Earnings are expected to go from $0.11 to $0.15, a 21% earnings growth. Against a 15 P/E gives you a .8 P/E to growth. If the market pulls back you may be able to buy it below $2.2005-09-15
DON'T BUY2.300Jean-Francois TardifHas disappointed him in the past and seems to do this all the time. Recent results don't look very good to him. Made a lot of acquisitions, but earnings are not that good.2005-08-29
PAST TOP PICK1.550Brendan Kyne(A Top Pick Nov 19/03. Down 37%.) Sold off some time ago. Company is fairly sound and has cash.2005-05-31
TOP PICK1.480Werner MuehelemannTechnology stock valuations have come down a lot and is a sector that still has potential to grow. Trades around 11 X forward earnings which is pretty cheap. They are going to double their earnings from last year's. Likes the health care sector that they are in. Revenue model is going more to a transactional basis rather than license.2005-03-23
DON'T BUY1.350Robert McWhirterRanks borderline of the bottom 1/3 of the database. Earnings estimates have been revised downward. 12 PE overall for reasonable are ROE of 21%.2004-08-20
BUY1.120John EmbryLikes management. As an interesting land package in Chile. Speculative.2004-04-15
WAIT1.870Peter HodsonExpect the stock won't do a lot until they do a major acquisition along with a finance. Well-run.2004-04-08
BUY1.850Ed HoDropped because of speculation in the market that they were going to do an acquisition. Likes management. Have good revenue and are growing reasonably.2004-03-24
WAIT2.450Robert McWhirterAbout mid-point in the database. The large contract they have, runs out of steam the middle of this year.2004-01-30
DON'T BUY2.250Andrew McCreathNot a big fan of medical tech system companies. Stocks had big run. Wouldn't buy at this level.2004-01-28
DON'T BUY2.200Andrew McCreathNot a big fan of medical technology information systems as so many have had good stories, but never made any money.2004-01-26
BUY on WEAKNESS2.240Peter HodsonLikes the company. Have had some pretty good traction. Likes the space. Would buy under $2.2004-01-23
BUY2.500Robert McWhirterRanks very well in the database. Year-over-year earnings growth is up 40%. ROE is expected to be 41%.2004-01-05
TOP PICK2.230Brendan KyneEarnings growth is consistent 65% of earnings is recurring which is very high. Very cheap on a multiples basis.2003-12-17
BUY2.370Peter HodsonA bit of an overhang in that there is a lot of stock for sale. Starting to get traction with their customers. Might go to $3.50/4 long-term. An acquisition target.2003-12-04
BUY2.440Robert McWhirterHas done very well and thinks there is still opportunity. In the top 8% of the database. Earnings are expected to grow from 13¢ to 17¢. Continuing to work on some very large contracts and hopefully they will be closed in the new year.2003-11-21
TOP PICK2.480Brendan KyneHas delivered 2 very profitable quarters, 3¢ a share and are looking for them to earn 12¢ 13¢ for the Feb year-end and .20¢ next year. Probably will be a takeover.2003-11-19
WAIT2.000Peter HodsonThere is some profit taking going on. There is a big overhang in that some dealers are try to get rid of a block which is putting short-term pressure on the stock. Still a good story. This space is pretty strong. Expected to be acquired ultimately.2003-11-14
BUY2.340Robert McWhirterRanks high in the model. Earnings are forecast to grow from 0.14¢ 0.17¢. A 15% earnings growth against a 15 P/E, gives a good P. E. growth. Year-over-year sales growth is pretty good.2003-11-07
BUY2.460Glenn Paradis, BA, CFALikes the business. They understand the dynamics of the industry. A lot of opportunity for them to continue to grow top and bottom. Good price. A little bit risky.2003-10-24
DON'T BUY2.310Andrew McCreathA pretty tough industry to consistently make money in. Has delivered, but feels the shares are a little pricey.2003-10-20
BUY2.860Robert McWhirterRanks as #6 in the Canadian database on techs. Still thinks there is good opportunity going forward. Earnings are expected to grow from $0.08 to $.13 per share. They are bidding on some very interesting contracts.2003-10-10
DON'T BUY2.510Robert FloydWould prefer at a lower price.2003-09-22
BUY2.590Peter HodsonNew management has turned the company around. Starting to get an accelerating contract win situation. (Do back office transaction between pharmacies, payer, insurance company, etc. Good product.) Winning market share.2003-09-09
BUY2.650Robert McWhirter60% of their revenue is recurring. Strong transaction based. Still pretty good opportunities. Should be more upside.2003-08-29
TOP PICK2.520Kyle McKayEstimating that they will do about $15 million in revenues and $16/18 per share. Good price.2003-08-28
STRONG BUY2.200Brendan KyneSoftware company that facilitates connection between the pharmacy and insurance company.Earnings should go up.No debt.Trading below 10 times earnings.A great story.2003-08-26
BUY1.100Robert McWhirterHas just broken out from a technical analysis. Working on some long term contracts. Should move forward.2003-05-16
WEAK BUY0.780Robert McWhirterOK earnings. Outlook is pretty good, but a speculative buy.2003-01-24
BUY0.620Ray SteeleShould start to perform better. High volumes and low margins.2002-12-04
TOP PICK0.800Malvin SpoonerExpect a lot of growth in this sector2001-03-14
BUY0.730Malvin SpoonerStock has dropped because they are trying to raise money and trying to take over their competitors.2001-02-20
BUY2.000Bruce SelleryCheap as a tech. Small volume2000-10-03

Privacy Policy



Other worthy sites:

Powered by phpMyEdit of Platon Group
Life Insurance Canada - Canadian life insurance broker with online life insurance shopping.
American Universal Life Insurance
American term life insurance quotes
Canadian term life insurance rates
Our Main Page

www.financialwebring.com